A phase IV, open label, randomized, multicountry study to evaluate immunogenicity and safety of GSK Biologicals' seasonal (2010-2011) influenza vaccine FluarixTM in children previously vaccinated with GSK Biologicals' H1N1 vaccine (PandemrixTM).
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Hepatitis A vaccine inactivated; Influenza virus vaccine
- Indications Hepatitis A; Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 10 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2011 Actual end date (1 May 2011) added as reported by ClinicalTrials.gov.
- 10 Jun 2011 Actual patient number 162 added as reported by ClinicalTrials.gov.